@beautywithaj's peptide therapy claims need more evidence

What did @beautywithaj actually say?

The creator held up a blue peptide, likely GHK-Cu (copper peptide), and ran through a list of conditions it supposedly helps: old injuries, slow workout recovery, gut inflammation, skin firmness loss, chronic pain, and collagen decline. She called it "the clo blend" and framed it as something that "supports your body so it can support you." The pitch ended with an offer to tell viewers where to buy it.

To be fair, she used the word "supports" repeatedly rather than "cures" or "treats," which is a meaningful distinction. But stringing together that many conditions in 60 seconds, with no caveats, no mention of clinical status, and a direct purchase offer, is still a lot to unpack.

Does the science back this up?

Some of it, in limited contexts. GHK-Cu has real preclinical data behind it, but the gap between lab findings and human clinical outcomes is significant and often glossed over in peptide content.

GHK-Cu is a naturally occurring copper-binding tripeptide. It has demonstrated activity in wound healing and skin remodeling in cell and animal studies. Pickart et al. (2015, Journal of Aging Research) documented its role in stimulating collagen synthesis and activating antioxidant pathways. That part has some grounding.

On inflammation, there is cell-culture evidence that GHK-Cu downregulates pro-inflammatory cytokines including TNF-alpha and IL-6 (Pickart & Margolina, 2018, Biomolecules). For gut inflammation and chronic pain, the evidence is either extremely preliminary or absent in controlled human trials. Claims about back pain, shoulder pain, and knee pain have essentially no human RCT data supporting GHK-Cu specifically.

What did they get wrong (or right)?

She got the skin and collagen angle roughly right. GHK-Cu is probably the most evidence-adjacent claim she made. Topical GHK-Cu has shown measurable effects on skin thickness and elasticity in small human trials (Finkley et al., 1996, Cosmetics & Toiletries). That is real data.

She got the "old injuries" and pain claims wrong by omission. There is no published human trial showing GHK-Cu resolves chronic musculoskeletal injuries. Listing back pain, shoulder pain, and knee pain as things this peptide addresses implies a clinical evidence base that simply does not exist yet.

The gut inflammation claim is the weakest. Peptides like BPC-157 have more preclinical GI data than GHK-Cu. Attaching gut healing to this specific peptide without clarification is misleading.

The purchase offer at the end is a red flag. Peptides sold outside of licensed compounding pharmacies with a valid prescription exist in a legally and quality-control ambiguous space. That context was absent entirely.

What should you actually know?

GHK-Cu is not a scam, but it is not a proven treatment for most of what was listed. It is a research compound with interesting preclinical data and some limited human skin data. The FDA has not approved it as a drug for any indication, and as of 2024 the FDA and FTC have increased scrutiny of compounded peptide marketing.

If you are considering any peptide therapy, the conversation starts with a licensed clinician who can review your individual health history. "Supports" language in marketing does not carry the same weight as clinical evidence. A peptide that shows activity in a cell culture is a long distance from one that reliably resolves your chronic knee pain.

Sourcing matters enormously. Peptide quality, purity, and sterility vary widely. Products sold through social media referrals with no pharmacy verification carry real risk.

• GHK-Cu has legitimate skin and wound-healing research behind it
• Human RCT data for systemic pain or gut applications is essentially nonexistent
• Any peptide sourced without a prescription from a licensed compounding pharmacy raises safety and legality questions
• "Supports" is not the same as "treats" or "heals," even if it sounds like it